Items by By ANDREW POLLACK
NYT > Health
-
A Stem-Cell-Based Drug Gets Approval in Canada
Posted: May 18th, 2012, 2:53am EDT by By ANDREW POLLACK
Tags: [edit]
Prochymal, developed by Osiris Therapeutics, is a preparation of mesenchymal stem cells, which are obtained from the bone marrow of healthy young adult donors.
NYT > Business
-
A Stem-Cell-Based Drug Gets Approval in Canada
Posted: May 17th, 2012, 9:47pm EDT by By ANDREW POLLACK
Tags: [edit]
Prochymal, developed by Osiris Therapeutics, is a preparation of mesenchymal stem cells, which are obtained from the bone marrow of healthy young adult donors.
NYT > Health
-
Zytiga, a Prostate Cancer Drug, Does Well in Trial
Posted: May 17th, 2012, 4:00pm EDT by By ANDREW POLLACK
Tags: [edit]
In a small clinical trial, six months of treatment with the drug Zytiga, added to standard therapy, eliminated or nearly eliminated tumors in about one-third of men whose disease had not yet spread beyond the prostate gland.
-
Diet Drug Wins Approval of F.D.A. Advisers
Posted: May 11th, 2012, 3:26pm EDT by By ANDREW POLLACK
Tags: [edit]
Government advisers recommended that the F.D.A. approve the weight-loss drug lorcaserin.
-
Dow Corn, Resistant to a Weed Killer, Runs Into Opposition
Posted: April 26th, 2012, 2:26pm EDT by By ANDREW POLLACK
Tags: [edit]
Some environmental and consumer groups say that increased use of Dow Chemical’s herbicide, 2,4-D, could cause cancer, hormone disruption and other health problems.
NYT > Business
-
AstraZeneca C.E.O. to Step Down
Posted: April 26th, 2012, 2:01pm EDT by By ANDREW POLLACK
Tags: [edit]
David Brennan is leaving as the big British pharmaceutical company struggles with generic competition and lower revenue and profits.
NYT > Health
-
Drug Collaboration Lags on Hepatitis Treatment
Posted: April 20th, 2012, 1:17pm EDT by By ANDREW POLLACK
Tags: [edit]
A combination of two pills proved extremely effective in a small trial but the two companies who manufacture the pills have not agreed to collaborate, to the chagrin of some doctors.
-
E.P.A. Denies Request to Ban 2,4-D, a Popular Weed Killer
Posted: April 10th, 2012, 12:13pm EDT by By ANDREW POLLACK
Tags: [edit]
The agency said that the group, the Natural Resources Defense Council, had failed to show that the popular herbicide was harmful as used.
NYT > Business
-
E.P.A. Denies Request to Ban 2,4-D, a Popular Weed Killer
Posted: April 9th, 2012, 10:52pm EDT by By ANDREW POLLACK
Tags: [edit]
The agency said that the group, the Natural Resources Defense Council, had failed to show that the popular herbicide was harmful as used.
NYT > Health
-
Panel Recommends More Testing For Obesity Drugs
Posted: March 30th, 2012, 1:17pm EDT by By ANDREW POLLACK
Tags: [edit]
An advisory panel of the F.D.A. said obesity drugs should get extra testing to ensure against heart attacks and strokes.
-
Amgen Loses Monopoly on Drug for Dialysis Patients
Posted: March 29th, 2012, 1:12pm EDT by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.
-
Trial Shows Benefit in Earlier Use of Zytiga
Posted: March 9th, 2012, 10:13am EST by By ANDREW POLLACK
Tags: [edit]
The study of Zytiga from Johnson & Johnson also showed that it could pose a competitive threat to a rival drug, Provenge from Dendreon.
NYT > Business
-
Trial Shows Benefit in Earlier Use of Zytiga for Prostate Cancer
Posted: March 8th, 2012, 7:52pm EST by By ANDREW POLLACK
Tags: [edit]
The study of Zytiga from Johnson & Johnson also showed that it could pose a competitive threat to a rival drug, Provenge from Dendreon.
-
F.D.A. Backs Respiratory Distress Drug For Babies
Posted: March 7th, 2012, 1:30am EST by By ANDREW POLLACK
Tags: [edit]
The drug, Surfaxin, which helps premature babies with their breathing, won approval on its fifth try.
NYT > Health
-
F.D.A. Backs Respiratory Distress Drug For Babies
Posted: March 7th, 2012, 1:30am EST by By ANDREW POLLACK
Tags: [edit]
The drug, Surfaxin, which helps premature babies with their breathing, won approval on its fifth try.
NYT > Business
-
Dr. Craig B. Thompson, Head of Sloan-Kettering, Is Sued
Posted: February 23rd, 2012, 1:00am EST by By ANDREW POLLACK
Tags: [edit]
The University of Pennsylvania filed the suit against Dr. Craig B. Thompson, claiming he improperly used research done at the university to start a pharmaceutical company.
NYT > Health
-
Dr. Craig B. Thompson, Head of Sloan-Kettering, Is Sued
Posted: February 23rd, 2012, 1:00am EST by By ANDREW POLLACK
Tags: [edit]
The University of Pennsylvania filed the suit against Dr. Craig B. Thompson, claiming he improperly used research done at the university to start a pharmaceutical company.
NYT > Business
-
Qnexa Weight-Loss Drug Wins Advisory Panel’s Support
Posted: February 23rd, 2012, 12:30am EST by By ANDREW POLLACK
Tags: [edit]
A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years.
NYT > Health
-
Qnexa Weight-Loss Drug Wins Advisory Panel’s Support
Posted: February 23rd, 2012, 12:30am EST by By ANDREW POLLACK
Tags: [edit]
A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years.
NYT > Home Page
-
Qnexa Weight-Loss Drug Wins Advisory Panel’s Support
Posted: February 23rd, 2012, 12:30am EST by By ANDREW POLLACK
Tags: [edit]
A committee recommended that the Food and Drug Administration approve what could become the first new prescription drug to treat obesity in 13 years.
NYT > Health
-
Exemestane, Thought to Prevent Cancer, Also Causes Bone Loss
Posted: February 7th, 2012, 3:05am EST by By ANDREW POLLACK
Tags: [edit]
A drug that scientists had hoped would help prevent breast cancer has a significant side effect.
NYT > Business
-
Cancer Center, in Suit, Claims Ex-Official Took Research
Posted: February 6th, 2012, 10:03am EST by By ANDREW POLLACK
Tags: [edit]
The president of Memorial Sloan-Kettering Cancer Center, Dr. Craig B. Thompson, is in a billion-dollar dispute with his former workplace over accusations that he walked away with research.
NYT > Health
-
Cancer Center, in Suit, Claims Ex-Official Took Research
Posted: February 6th, 2012, 10:03am EST by By ANDREW POLLACK
Tags: [edit]
The president of Memorial Sloan-Kettering Cancer Center, Dr. Craig B. Thompson, is in a billion-dollar dispute with his former workplace over accusations that he walked away with research.
NYT > Business
-
F.D.A. Approves Cystic Fibrosis Drug
Posted: January 31st, 2012, 7:52pm EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration called Kalydeco a “breakthrough therapy” because it treats the underlying cause of the genetic disease, rather than just the symptoms.
NYT > Health
-
F.D.A. Approves Cystic Fibrosis Drug
Posted: January 31st, 2012, 7:52pm EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration called Kalydeco a “breakthrough therapy” because it treats the underlying cause of the genetic disease, rather than just the symptoms.
NYT > Home Page
-
F.D.A. Approves Cystic Fibrosis Drug
Posted: January 31st, 2012, 7:52pm EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration called Kalydeco a “breakthrough therapy” because it treats the underlying cause of the genetic disease, rather than just the symptoms.
NYT > Business
-
Prescriptions Blog: F.D.A. Approves Drug for an Advanced Skin Cancer
Posted: January 30th, 2012, 3:44pm EST by By ANDREW POLLACK
Tags: [edit]
The drug, Erivedge, made by Genentech, was approved for adults with basal cell carcinoma that has spread elsewhere in the body or those who are not candidates for surgery or radiation.
NYT > Health
-
Prescriptions Blog: F.D.A. Approves Drug for an Advanced Skin Cancer
Posted: January 30th, 2012, 3:44pm EST by By ANDREW POLLACK
Tags: [edit]
The drug, Erivedge, made by Genentech, was approved for adults with basal cell carcinoma that has spread elsewhere in the body or those who are not candidates for surgery or radiation.
-
Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval
Posted: January 28th, 2012, 1:10am EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.
NYT > Business
-
Bydureon, a Diabetes Drug from Amylin, Wins F.D.A. Approval
Posted: January 27th, 2012, 8:00pm EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration twice declined to approve Bydureon in 2010, with its most serious concern being that the drug might contribute to heart rhythm abnormalities.
NYT > Health
-
Embryonic Stem Cell Study Shows Promise
Posted: January 24th, 2012, 12:43am EST by By ANDREW POLLACK
Tags: [edit]
A treatment that improved the vision of two women with forms of macular degeneration could be a breakthrough for regenerative medicine after a recent setback.
-
Prescriptions Blog: F.D.A. Delays Approval of New Diabetes Drug
Posted: January 19th, 2012, 2:17pm EST by By ANDREW POLLACK
Tags: [edit]
Federal drug regulators are seeking more data from AstraZeneca and Bristol-Myers Squibb before deciding whether to approve dapagliflozin, a new drug aimed at Type 2 diabetes.
-
Prescriptions Blog: New Questions Raised About Tamiflu's Effectiveness
Posted: January 17th, 2012, 7:01pm EST by By ANDREW POLLACK
Tags: [edit]
A new study by the Cochrane Collaboration finds that the Roche drug Tamiflu does not reduce flu complications and transmission as much as previous studies suggested.
NYT > Business
-
Pressure to Link Drugs and ‘Companion Diagnostics’
Posted: December 26th, 2011, 9:29pm EST by By ANDREW POLLACK
Tags: [edit]
The F.D.A. issued guidance to the industry on companion diagnostics in July, including its preference for having the test ready for approval at the same time as the drug.
NYT > Health
-
Pressure to Link Drugs and ‘Companion Diagnostics’
Posted: December 26th, 2011, 9:29pm EST by By ANDREW POLLACK
Tags: [edit]
The F.D.A. issued guidance to the industry on companion diagnostics in July, including its preference for having the test ready for approval at the same time as the drug.
NYT > Business
-
Amgen and Watson to Work Together on Generic Drugs
Posted: December 20th, 2011, 12:57am EST by By ANDREW POLLACK
Tags: [edit]
The two companies will develop and sell cheaper versions of several biologic cancer drugs.
NYT > Health
-
Amgen and Watson to Work Together on Generic Drugs
Posted: December 20th, 2011, 12:57am EST by By ANDREW POLLACK
Tags: [edit]
The two companies will develop and sell cheaper versions of several biologic cancer drugs.
-
2 Amgen Executives To Retire
Posted: December 18th, 2011, 4:50pm EST by By ANDREW POLLACK
Tags: [edit]
Kevin W. Sharer, the chief executive, and Dr. Roger M. Perlmutter, the head of research, will step down in 2012. The company’s growth has slowed in recent years.
-
Prescriptions Blog: New Setback for Avastin as Breast Cancer Treatment
Posted: December 9th, 2011, 9:44am EST by By ANDREW POLLACK
Tags: [edit]
The latest trial, had it been more successful, could have paved the way for a new approval.
-
Two Drugs Appear to Delay Progression of Breast Cancer
Posted: December 8th, 2011, 3:56pm EST by By ANDREW POLLACK
Tags: [edit]
Clinical trials of the treatments, from Novartis and Genentech, showed they could lengthen lives.
NYT > Business
-
Study Questions Brachytherapy, a Breast Cancer Radiation Treatment
Posted: December 7th, 2011, 1:11am EST by By ANDREW POLLACK
Tags: [edit]
Brachytherapy can be completed in a week, but it may not be as effective or safe as conventional radiation treatment.
-
Study Questions Brachytherapy, a Breast Cancer Radiation Treatment
Posted: December 7th, 2011, 1:11am EST by By ANDREW POLLACK
Tags: [edit]
Brachytherapy can be completed in a week, but it may not be as effective or safe as conventional radiation treatment.
NYT > Health
-
Study Questions Brachytherapy, a Breast Cancer Radiation Treatment
Posted: December 7th, 2011, 1:11am EST by By ANDREW POLLACK
Tags: [edit]
Brachytherapy can be completed in a week, but it may not be as effective or safe as conventional radiation treatment.
-
Prescriptions Blog: New Breast Cancer Test May Help Curtail Treatments
Posted: December 6th, 2011, 6:30pm EST by By ANDREW POLLACK
Tags: [edit]
Results on the accuracy of the test, known as Oncotype DX, will be released by Genomic Health at a breast cancer symposium on Thursday.
-
Some Stem Cell Donors Can Be Paid, Court Rules
Posted: December 2nd, 2011, 3:50pm EST by By ANDREW POLLACK
Tags: [edit]
An appeals court says a law prohibiting payment for donated organs did not apply to stem cells extracted from circulating blood.
-
DNA Sequencing Caught in Deluge of Data
Posted: December 2nd, 2011, 2:20am EST by By ANDREW POLLACK
Tags: [edit]
DNA sequencing is becoming faster and cheaper, outrunning the ability to store, transmit and analyze the data.
-
New Hope of a Cure for H.I.V.
Posted: November 30th, 2011, 2:00am EST by By ANDREW POLLACK
Tags: [edit]
Timothy Brown of San Francisco had two bone-marrow transplants to treat leukemia, and H.I.V. can no longer be detected in his body.The experiences of two patients now suggest to many scientists that a cure may be achievable even if it is years away.
-
Prescriptions Blog: A Step Forward for RNA Interference
Posted: November 21st, 2011, 12:17pm EST by By ANDREW POLLACK
Tags: [edit]
Alnylam Pharmaceuticals says it has developed a drug using the technique of RNA interference that appears to work in people, providing a proof of concept.
-
Deal Assures Market for Anemia Drug
Posted: November 19th, 2011, 3:17am EST by By ANDREW POLLACK
Tags: [edit]
DaVita, a dialysis chain, has agreed to make major purchases of Epogen, the Amgen drug, to help the manufacturer as it faces new competition.
-
F.D.A. Revokes Approval of Avastin for Use as Breast Cancer Drug
Posted: November 19th, 2011, 12:34am EST by By ANDREW POLLACK
Tags: [edit]
The agency said the drug “has not been shown to be safe and effective” for breast cancer patients, but would remain available for treating other types of cancer.
-
Prescriptions Blog: F.D.A. Approves Drug for Bone Marrow Disease
Posted: November 16th, 2011, 6:24pm EST by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration approved Incyte to be the first drug to treat myelofibrosis, a rare but potentially life-threatening bone marrow disorder.
-
Prescriptions Blog: Amylin and Eli Lilly Part Ways Over Diabetes Drug
Posted: November 8th, 2011, 12:08pm EST by By ANDREW POLLACK
Tags: [edit]
The smaller company objected to Eli Lilly's work with what it considered a competing diabetes drug.
-
Prescriptions Blog: Depression Drug Results Disappoint Targacept and AstraZeneca
Posted: November 8th, 2011, 12:00pm EST by By ANDREW POLLACK
Tags: [edit]
An experimental drug was failing in late-stage clinical trials.
-
Prescriptions Blog: For Prostate Screening Guidelines, Public Comments Are Private
Posted: November 4th, 2011, 1:56pm EDT by By ANDREW POLLACK
Tags: [edit]
The task force that recommended that men can forgo prostate screening is seeking reaction, but responses are not publicly available.
-
Prescriptions Blog: Prostate Cancer Drug Shows Promise in Study
Posted: November 3rd, 2011, 2:22pm EDT by By ANDREW POLLACK
Tags: [edit]
Medivation announced that a late-stage clinical trial was so successful that it was stopped early to provide the drug to all participants.
-
Prescriptions Blog: Vertex Bests Merck in New Hepatitis C Drug Sales
Posted: October 28th, 2011, 4:44pm EDT by By ANDREW POLLACK
Tags: [edit]
The new treatments were approved only last spring.
NYT > Business
-
Amgen to Pay $780 Million to Settle Marketing Accusations
Posted: October 25th, 2011, 1:21am EDT by By ANDREW POLLACK
Tags: [edit]
Lawsuits accused the drug company of illegal sales and marketing tactics.
NYT > Health
-
Prescriptions Blog: The Quandary Posed by a New Down Syndrome Test
Posted: October 19th, 2011, 6:43pm EDT by By ANDREW POLLACK
Tags: [edit]
Advocates are concerned that a noninvasive test to determine if a fetus has Down syndrome will lead to more pregnancies being terminated.
-
Sequenom’s Test for Down Syndrome Raises Hopes and Questions
Posted: October 18th, 2011, 11:40am EDT by By ANDREW POLLACK
Tags: [edit]
The new test may reduce the need for riskier invasive procedures like amniocentesis, but it raises ethical issues.
-
Blue Shield of California Won’t Cover Breast Cancer Drug
Posted: October 5th, 2011, 1:40pm EDT by By ANDREW POLLACK
Tags: [edit]
After doubts about the drug’s efficacy, the Food and Drug Administration is considering whether to rescind approval of it for the treatment of breast cancer.
-
Prescriptions Blog: Doctors Grow Wary of Avastin for Eye Treatment
Posted: October 4th, 2011, 8:56pm EDT by By ANDREW POLLACK
Tags: [edit]
A spate of infections, leaving some patients blind, has caused some physicians to choose the more expensive Lucentis for eye disease in the elderly.
-
Prescriptions Blog: Orexigen and F.D.A. Revive Study of Contrave, a Diet Pill
Posted: September 21st, 2011, 10:48am EDT by By ANDREW POLLACK
Tags: [edit]
The Food and Drug Administration and Orexigen reached agreement on new trial standards for Contrave, a pill the agency had rejected earlier this year.
-
Prescriptions Blog: Obama Pushes More Competition on Biologic Drugs
Posted: September 20th, 2011, 8:51am EDT by By ANDREW POLLACK
Tags: [edit]
The industry had fought against a seven-year limit during the health care debate and managed to get 12 years in the final legislation.
-
Patent Bill Viewed as Bailout for a Law Firm
Posted: September 8th, 2011, 12:40am EDT by By ANDREW POLLACK
Tags: [edit]
A provision in a bill before the Senate could get an influential law firm off the hook for a possible $214 million malpractice payment.
-
Patent Bill Viewed as Bailout for a Law Firm
Posted: September 8th, 2011, 12:40am EDT by By ANDREW POLLACK
Tags: [edit]
A provision in a bill before the Senate could get an influential law firm off the hook for a possible $214 million malpractice payment.
NYT > Business
-
More Reports of Avastin Injections Causing Blindness
Posted: September 1st, 2011, 9:41pm EDT by By ANDREW POLLACK
Tags: [edit]
Five more patients who were being treated with the drug Avastin for eye disease have been blinded, according to one of the patients and medical professionals.
NYT > Health
-
More Reports of Avastin Injections Causing Blindness
Posted: September 1st, 2011, 9:41pm EDT by By ANDREW POLLACK
Tags: [edit]
Five more patients who were being treated with the drug Avastin for eye disease have been blinded, according to one of the patients and medical professionals.
-
Avastin Injections Are Said to Cause Blindness
Posted: August 31st, 2011, 1:23am EDT by By ANDREW POLLACK
Tags: [edit]
Avastin, sold by Genentech, is approved to treat cancer, not eye disease, but many doctors use it because it is many times cheaper than an alternative drug.
NYT > Business
-
Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts
Posted: August 11th, 2011, 10:23pm EDT by By ANDREW POLLACK
Tags: [edit]
As competition for patients and treatments intensifies, more medical centers are offering a controversial procedure in which inner organs are bathed in hot chemotherapy drugs.
-
Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts
Posted: August 11th, 2011, 10:23pm EDT by By ANDREW POLLACK
Tags: [edit]
As competition for patients and treatments intensifies, more medical centers are offering a controversial procedure in which inner organs are bathed in hot chemotherapy drugs.
NYT > Health
-
Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts
Posted: August 11th, 2011, 10:23pm EDT by By ANDREW POLLACK
Tags: [edit]
As competition for patients and treatments intensifies, more medical centers are offering a controversial procedure in which inner organs are bathed in hot chemotherapy drugs.
-
Hot Chemotherapy Bath: Patients See Hope, Critics Hold Doubts
Posted: August 11th, 2011, 10:23pm EDT by By ANDREW POLLACK
Tags: [edit]
As competition for patients and treatments intensifies, more medical centers are offering a controversial procedure in which inner organs are bathed in hot chemotherapy drugs.
-
Some Stealth Marketing by a ‘Hot Chemo’ Company
Posted: August 11th, 2011, 10:20pm EDT by By ANDREW POLLACK
Tags: [edit]
One site promoting the hot chemotherapy bath gives no hint that it is owned by a manufacturer of the necessary equipment.
-
Some Stealth Marketing by a ‘Hot Chemo’ Company
Posted: August 11th, 2011, 10:20pm EDT by By ANDREW POLLACK
Tags: [edit]
One site promoting the hot chemotherapy bath gives no hint that it is owned by a manufacturer of the necessary equipment.
-
Pfizer Is Said to Pursue Nonprescription Lipitor
Posted: August 4th, 2011, 1:00am EDT by By ANDREW POLLACK
Tags: [edit]
Pfizer hopes to have an over-the-counter version of the world’s best-selling drug after it loses patent protection.
-
Ruling Upholds Gene Patent in Cancer Test
Posted: July 30th, 2011, 12:30am EDT by By ANDREW POLLACK
Tags: [edit]
A federal appeals court ruled on Friday that genes can be patented, overturning a lower court decision that had shocked the biotechnology industry.
-
Lawsuit Says Drugs Were Wasted to Buoy Profit
Posted: July 26th, 2011, 11:50am EDT by By ANDREW POLLACK
Tags: [edit]
DaVita is accused of using large vials of dialysis medicine knowing that Medicare would pay for the unused portion.
-
Rule Changes Proposed for Research on Humans
Posted: July 25th, 2011, 12:50am EDT by By ANDREW POLLACK
Tags: [edit]
Officials say that proposed changes would strengthen protections while reducing red tape that impedes studies.
-
Diabetes Drug Dapagliflozin Rejected by F.D.A. Panel
Posted: July 20th, 2011, 3:46am EDT by By ANDREW POLLACK
Tags: [edit]
In testing, a first-of-its-kind diabetes drug raised safety concerns, including a possible increased risk of breast and bladder cancers.
-
New Diabetes Drug Faces a Critical Review Before an F.D.A. Advisory Panel
Posted: July 18th, 2011, 1:58am EDT by By ANDREW POLLACK
Tags: [edit]
An F.D.A. advisory committee is set this week to consider whether dapagliflozin can overcome safety concerns and reach the market.
-
Medicare Will Continue to Cover 2 Expensive Cancer Drugs
Posted: July 1st, 2011, 1:00am EDT by By ANDREW POLLACK
Tags: [edit]
Drugs for prostate and breast cancer will still be covered by Medicare, despite their high costs and recent debate about the effectiveness of one.
-
Panel Advises F.D.A. to Narrow Its Approval for Avastin
Posted: June 30th, 2011, 12:59am EDT by By ANDREW POLLACK
Tags: [edit]
In a series of 6-0 votes, an advisory committee to the F.D.A. endorsed the agency’s proposal to revoke the approval of the drug for use against advanced breast cancer.
-
Breast Cancer Patients Plead for Avastin Approval
Posted: June 29th, 2011, 1:03am EDT by By ANDREW POLLACK
Tags: [edit]
With breast cancer patients imploring the Food and Drug Administration to change course, the agency’s staff argued that the drug Avastin should lose its approval as a treatment for that disease.
NYT > Business
-
New Drugs Fight Prostate Cancer, but at High Cost
Posted: June 28th, 2011, 1:06am EDT by By ANDREW POLLACK
Tags: [edit]
The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.
NYT > Health
-
New Drugs Fight Prostate Cancer, but at High Cost
Posted: June 28th, 2011, 1:06am EDT by By ANDREW POLLACK
Tags: [edit]
The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.
NYT > Home Page
-
New Drugs Fight Prostate Cancer, but at High Cost
Posted: June 28th, 2011, 1:06am EDT by By ANDREW POLLACK
Tags: [edit]
The drugs, mainly for men with late-stage prostate cancer, can extend lives for additional months, but some cost more than $90,000 for a course of treatment.
NYT > Health
-
Drugs Show Promise Slowing Advanced Melanoma
Posted: June 8th, 2011, 1:22pm EDT by By ANDREW POLLACK
Tags: [edit]
Two drugs can prolong the lives of people with advanced melanoma in what researchers call notable progress.
-
Drug Can Reduce Risk of Breast Cancer, Study Says
Posted: June 5th, 2011, 1:48am EDT by By ANDREW POLLACK
Tags: [edit]
A drug now used to prevent recurrences of breast cancer can also prevent it from occurring in the first place.
-
F.D.A. Approves Drug to Treat Hospital Scourge
Posted: May 28th, 2011, 2:55am EDT by By ANDREW POLLACK
Tags: [edit]
The drug, called Dificid, is the first new medicine in 25 years approved to treat diarrhea caused by Clostridium difficile, a nasty and persistent bacterium.
-
A Blood Test Offers Clues to Longevity
Posted: May 18th, 2011, 10:10pm EDT by By ANDREW POLLACK
Tags: [edit]
Some experts say that blood tests that seek to tell people their biological age do not provide useful information.
NYT > Business
-
A Blood Test Offers Clues to Longevity
Posted: May 18th, 2011, 9:53pm EDT by By ANDREW POLLACK
Tags: [edit]
Some experts say that blood tests that seek to tell people their biological age do not provide useful information.
NYT > Home Page
-
A Blood Test Offers Clues to Longevity
Posted: May 18th, 2011, 9:53pm EDT by By ANDREW POLLACK
Tags: [edit]
Some experts say that blood tests that seek to tell people their biological age do not provide useful information.
NYT > Health
-
Merck’s Hepatitis C Drug Wins F.D.A. Approval
Posted: May 14th, 2011, 2:30am EDT by By ANDREW POLLACK
Tags: [edit]
Victrelis, from Merck, is the first of a new generation of drugs that promise to increase the cure rate while shortening the treatment time.
-
Setback for New Stem Cell Treatment
Posted: May 14th, 2011, 2:20am EDT by By ANDREW POLLACK
Tags: [edit]
Induced pluripotent stem cells appear to have the healing potential of embryonic stem cells without the controversy, but when given to mice, they didn’t survive the immune response.
NYT > Business
-
Many Japanese Factories Recover After Quake
Posted: May 2nd, 2011, 1:12am EDT by By ANDREW POLLACK
Tags: [edit]
Ricoh, a maker of copiers, swung into action after the March earthquake and has nearly recovered. Japan says 64 percent of damaged factories have bounced back.
NYT > Health
-
Cheaper Drug to Treat Eye Disease Is Effective
Posted: April 29th, 2011, 1:03am EDT by By ANDREW POLLACK
Tags: [edit]
The trial said that Avastin is just as effective at treating a form of macular degeneration as the more expensive Lucentis.
-
After Japan Crisis, New Urgency for Radiation Drugs
Posted: April 3rd, 2011, 4:06pm EDT by By ANDREW POLLACK
Tags: [edit]
Experts say that progress has been made in developing treatments for radiation poisoning. But many obstacles remain.
-
A Panel Decides Washington State’s Health Care Costs
Posted: March 22nd, 2011, 1:10am EDT by By ANDREW POLLACK
Tags: [edit]
The committee has authority to determine which medical devices and procedures the state will cover for its employees, Medicaid patients and injured workers.
-
The Big Picture: Hoping to Avoid the Knife
Posted: March 17th, 2011, 1:03am EDT by By ANDREW POLLACK
Tags: [edit]
Entrepreneurs haven’t yet struck gold in their search for an incision-free procedure to help millions of obese Americans, but it isn’t for lack of effort.
-
Anxiety Over Radiation Drives a Sales Surge for a Drug Against Thyroid Cancer
Posted: March 16th, 2011, 1:53am EDT by By ANDREW POLLACK
Tags: [edit]
Leaks from nuclear plants in Japan have created a demand for potassium iodide, a drug that can protect people from thyroid cancer.